- Pflugfelder honored for contributions to ophthalmology
Dr. Stephen Pflugfelder, professor of ophthalmology, delivered the Binkhorst Lecture and received the Binkhorst Medal at the annual meeting of the American Society of Cataract and Refractive Surgery / American Society of Ophthalmic Administrators, held May 3-7 in San Diego. This honor is conferred annually on the world's most prominent ophthalmologists and recognizes Pflugfelder for his significant contributions to the science and practice of ophthalmology. His talk was titled, "The Quest for Tear Stability."
- Shetlar Elected President-Elect of AAOOP
Dr. Debra Shetlar, associate professor of ophthalmology, was elected as president-elect of the American Association of Ophthalmic Oncologists and Pathologists at the society’s recent meeting in Chicago. She will serve as president of the society in 2020-2022.
- Rogers, Stout and Chen to develop new models for eye disease research
As part of a new $6 million grant from the NIH National Eye Institute, Drs. Jeffrey Rogers, Tim Stout and Rui Chen, along with colleagues at UC Davis, will study naturally-occurring ocular diseases in nonhuman primate models of human retinal disease, and use those models to develop therapies for the loss of photoreceptor cells in the retina.
- Fu awarded for macular degeneration research
Dr. Yingbin Fu, associate professor and the Sarah Campbell Blaffer Endowed Chair in ophthalmology, has earned the 2018 Helen Juanita Reed Award for Macular Degeneration from the BrightFocus Foundation. Fu's lab studies the biological mechanisms underlying various types of neurodegeneration and aging. The award will be presented at the Association for Vision and Ophthalmology annual conference held in April in Honolulu.
- Lewis awarded the 2018 Marshall Parks Bronze Medal
Dr. Richard Lewis, professor of molecular and human genetics, ophthalmology, pediatrics and medicine, was awarded the 2018 Marshall Parks Bronze Medal from the American Association of Pediatric Ophthalmology and Strabismus at its 44th Annual Meeting in Washington D.C. Lewis is the first non-pediatric ophthalmologist to be honored. He was recognized as the major intellectual force in applying molecular technologies to inherited ocular disorders especially afflicting infants, children and adolescents. He has authored more than 520 publications and holds 10 U.S. patents.
- Stout honored by eye institute
Dr. Timothy Stout, chair and professor of ophthalmology, was honored as the 2018 Distinguished Alumnus at the Doheny Eye Institute Society of Scholars annual alumni dinner on Jan. 6 in Los Angeles in recognition of his contributions to research, education and patient care. The dinner was part of the Doheny Society of Scholars and UCLA Ophthalmology Clinical Challenges Conference.
- Clinical trial helps bring sight to the blindJun 27, 2019
- In collaboration with the University of California, Los Angeles and Second Sight, Baylor College of Medicine is testing the Orion in the first-ever FDA-approved clinical trial of a visual cortical prosthesis.
- Researchers uncover mechanism blocking retina regenerationMay 7, 2019
- A discovery from researchers at Baylor College of Medicine and others opens the possibility of one day restoring loss of vision by activating the retina’s ability to regenerate.
- INSiGHT identifies unique retinal regulatory genesAug 29, 2018
- Researches at Baylor College of Medicine, Texas Children’s Hospital and the Hospital for Sick Children have developed a new platform called INSiGHT that enables them to uncover new regulators of retina neurons.
- What to know about protecting your eyes this summerJun 25, 2018
- From swimming at the pool to taking in fireworks displays, your eyes are sure to be exposed to sun and other hazards. An expert at Baylor College of Medicine shares her advice on ways to protect your eyes while still enjoying summer activities.
- Dive into a safe Memorial Day with these tipsMay 24, 2018
- Experts at Baylor College of Medicine offer advice on how to have a safe and fun Memorial Day weekend while spending time outdoors.
- New gene therapy shows promise in reversing vision loss or blindness in patients with rare diseaseApr 16, 2018
- A new FDA-approved gene therapy treatment for patients with an inherited form of vision loss is now available at Baylor College of Medicine.
- Knights Templar Eye Foundation gives $2M for endowed chairJan 5, 2018
- The Knights Templar Eye Foundation gifts Baylor College of Medicine $2 million to create the Knights Templar Eye Foundation Presidential Chair in Ophthalmology.